Last updated: May 23, 2026
In this article
- What “IBS” means in cats (and does not)
- The diagnostic exclusion cascade
- Why cobalamin matters
- Dietary trial as both treatment and diagnostic
- The hydrolyzed protein versus novel protein decision
- When biopsy becomes necessary
- Distinguishing IBD from small-cell intestinal lymphoma
- Pharmacologic management of true IBD
- The triaditis concept
- Antibiotic-responsive enteropathy
- Probiotics, prebiotics, and the microbiome
- Long-term diet and weight management
- Steroid side effects and stewardship
- Adopting a cat with IBD
- Frequently asked questions
Inflammatory bowel disease (IBD) in cats is a chronic enteropathy characterized by infiltration of inflammatory cells into the gastrointestinal mucosa. Clinically it produces some combination of chronic vomiting, chronic diarrhea, weight loss, and inappetence, often waxing and waning over months to years. The diagnostic challenge is that IBD is a histologic diagnosis, the working diagnostic process is largely about exclusion, and the most important differential, small-cell intestinal lymphoma, can look identical clinically and is treatable but requires different medication. This is an ACVIM-credentialed internist’s wheelhouse for complex cases.
What “IBS” means in cats (and does not)
Irritable bowel syndrome as a label is borrowed loosely from human medicine and is not a well-defined feline syndrome. In practice, cats with chronic GI signs fall along a spectrum of food-responsive enteropathy, antibiotic-responsive enteropathy, steroid-responsive (true IBD), and non-responsive (often small-cell lymphoma or other organic disease). The 2010s ACVIM literature increasingly describes this spectrum as “chronic enteropathy” rather than reflexively assigning “IBD.”
The diagnostic exclusion cascade
Before biopsy, the standard workup eliminates more straightforward causes. Fecal float and Giardia testing rule out intestinal parasites, including Tritrichomonas foetus in young cats. A full chemistry, CBC, T4, and feline pancreas-specific lipase (Spec fPL) screen for hyperthyroidism, kidney disease, diabetes, and pancreatitis (see feline pancreatitis management), all of which mimic or coexist with IBD. Abdominal ultrasound by a skilled imager assesses bowel wall thickness, layering, mesenteric lymph nodes, and rules out masses. B12 (cobalamin) and folate levels guide supplementation and help characterize small versus large bowel disease.
Why cobalamin matters
Cobalamin (vitamin B12) absorption in cats is unique. Cats lack salivary haptocorrin and rely heavily on pancreatic intrinsic factor for ileal cobalamin absorption. Chronic enteropathies, pancreatic insufficiency (exocrine pancreatic insufficiency, EPI), and ileal disease all produce cobalamin deficiency. Deficient cats have GI signs, weight loss, and sometimes neurologic signs that improve with parenteral or oral cobalamin supplementation independent of underlying disease treatment. Many IBD cats benefit substantially from cobalamin supplementation alone in the first weeks of management. Folate is similarly informative: elevated folate with low cobalamin suggests small intestinal bacterial dysbiosis. These two inexpensive blood tests, often run as part of the GI panel at IDEXX or Texas A&M, frequently steer management more than any other single result.
Dietary trial as both treatment and diagnostic
A strict 8 to 12 week dietary elimination trial is both treatment and diagnostic step. Two reasonable approaches: a hydrolyzed protein diet (Royal Canin Hydrolyzed Protein HP, Hill’s Prescription Diet z/d, Purina HA), in which protein is enzymatically broken down to fragments too small to provoke an allergic response, or a novel-protein diet using a protein source the cat has never encountered. The trial is only valid if it is truly exclusive, meaning no treats, no flavored medications, no shared food bowls in multi-cat homes, and no scavenging. Cats whose signs resolve on the diet have food-responsive enteropathy; this is a meaningful subset and often does not need immunosuppression. See prescription hydrolyzed protein diet and the elimination diet trial protocol.
The hydrolyzed protein versus novel protein decision
Both diet types can produce dietary remission. Hydrolyzed protein diets break protein into peptides too small for the immune system to recognize as antigens; novel protein diets use a protein source the cat has never previously eaten (rabbit, duck, venison, kangaroo depending on regional availability), relying on lack of prior sensitization. The hydrolyzed approach is more reliable because it does not depend on dietary history accuracy (and most cats have eaten more proteins than owners realize, especially shelter and rescue cats with unknown earlier diets). Novel protein costs less in some markets and may be more palatable for picky cats. The choice is collaborative with your vet; either is a legitimate first trial. Strict adherence is non-negotiable for the trial to be diagnostically useful: even small breaks (flavored treats, flavored medications, scavenged food, shared bowls in multi-cat homes) can invalidate the eight to twelve week assessment.
When biopsy becomes necessary
Cats that fail an adequate dietary trial, that have ultrasonographic findings suggestive of more than uncomplicated enteropathy (markedly thickened bowel wall, loss of layering, enlarged mesenteric nodes), or that have significant weight loss with hypoalbuminemia or hypocobalaminemia, are candidates for biopsy. Endoscopy provides mucosal biopsies of stomach and duodenum (and colon if relevant); full-thickness biopsies via exploratory laparotomy give a more complete picture, including jejunum and ileum which are common lymphoma sites. The 2018 World Small Animal Veterinary Association (WSAVA) histopathologic standards have improved diagnostic consistency for IBD versus lymphoma. Many cases still require immunohistochemistry and PARR (clonality) testing to definitively separate severe lymphocytic-plasmacytic IBD from small-cell intestinal lymphoma. See small-cell lymphoma in cats.
Distinguishing IBD from small-cell intestinal lymphoma
Small-cell intestinal lymphoma (almost always T-cell) and severe IBD overlap clinically and even histologically. The distinction matters because both can be treated with reasonable success in cats, but the treatment differs. Small-cell lymphoma is generally treated with chlorambucil plus prednisolone with median survival often exceeding two years in published series; severe IBD without lymphoma is treated with prednisolone with or without other immunomodulators. Many ACVIM internists will trial chlorambucil empirically in cats with strongly lymphoma-suspicious biopsies that lack definitive markers.
Pharmacologic management of true IBD
Prednisolone (preferred in cats over prednisone) is the foundational anti-inflammatory. Budesonide, an enteric-coated locally acting corticosteroid, is sometimes used to reduce systemic steroid effects, although evidence in cats is modest. Cyclosporine is reserved for refractory cases. Cobalamin (vitamin B12) supplementation is appropriate in any cat with documented deficiency. Folate supplementation is also indicated when low. We do not publish mg or mg per kg dosing here; that decision belongs to your AAFP-credentialed or ACVIM-credentialed prescriber based on weight, severity, response, and comorbidities. See the broader inflammatory bowel disease in cats overview.
The triaditis concept
Cats frequently have concurrent IBD, pancreatitis, and cholangitis or cholangiohepatitis. This triaditis pattern reflects the unique anatomy of the cat, in which the pancreatic and bile ducts join before entering the duodenum, so inflammation in one organ propagates to the others. A workup for IBD should always consider concurrent pancreatic and hepatic disease, and elevated fPL or liver enzymes do not rule out IBD; they often confirm triaditis.
Antibiotic-responsive enteropathy
A subset of cats respond to metronidazole or tylosin trials, suggesting dysbiosis or, less specifically, the anti-inflammatory effect of these agents. Antibiotic trials are not first-line in current feline GI practice given antimicrobial stewardship considerations, but they remain a recognized treatment category for specific refractory presentations.
Probiotics, prebiotics, and the microbiome
Microbiome modulation has moved from fringe to mainstream in feline GI management over the last decade. Veterinary-specific probiotic products (FortiFlora from Purina, Proviable from Nutramax, Visbiome veterinary) have demonstrated benefit in some controlled trials and clinical experience supports their use as adjuncts. Prebiotic fibers (psyllium, inulin) support beneficial bacterial populations. Fecal microbiota transplantation has emerging case-series evidence in refractory feline GI disease, primarily through veterinary teaching hospitals. The right framing: microbiome therapy is adjunctive, not a substitute for the diagnostic workup, but can meaningfully improve outcomes in stable maintenance cases.
Long-term diet and weight management
Many cats stabilize on a long-term therapeutic diet (hydrolyzed or novel protein) and rarely tolerate diet changes later. Weight should be monitored with a baby scale at home, ideally weekly, because progressive weight loss is often the earliest sign of relapse. Body condition score belongs in every recheck.
Steroid side effects and stewardship
Long-term prednisolone use in cats produces real side effects: polyuria and polydipsia (annoying for owners with multiple litter boxes), increased appetite, weight gain, fragile skin in some cats, and importantly increased diabetes risk. Cats are not infinitely steroid-tolerant despite the clinical folklore suggesting otherwise. The stewardship principle is to use the lowest effective dose for the shortest necessary period, taper to alternate-day dosing where possible, and consider steroid-sparing agents (cyclosporine, chlorambucil) in cats requiring sustained high-dose therapy. Periodic glucose checks in cats on chronic prednisolone are reasonable, especially in overweight cats and breeds predisposed to diabetes. Budesonide, which has high first-pass hepatic metabolism, is the standard alternative when systemic steroid effects are problematic, though evidence in cats is modest.
Adopting a cat with IBD
Cats with stable, well-managed IBD make rewarding adopters. Lifetime cost includes prescription diet, periodic bloodwork and ultrasound, and chronic medication. Disclosure to the adopter, written treatment plan, and continuity with an AAFP-credentialed or ACVIM-credentialed clinician set the cat up for success. See adopting a cat with IBD.
Frequently asked questions
What is the difference between IBD and food allergy in cats?
Food allergy can produce identical GI signs and is part of the chronic-enteropathy spectrum. The diagnostic dietary trial differentiates food-responsive cats (often labeled food allergy or food-responsive enteropathy) from truly steroid-dependent IBD.
Does my cat need a biopsy?
Not always. Many cats are managed on diet plus prednisolone empirically. Biopsy becomes important when response is poor, weight loss is significant, or when ultrasound or bloodwork suggests lymphoma.
Can IBD turn into lymphoma?
The relationship between chronic feline IBD and small-cell intestinal lymphoma is a live research question. Some cats progress from one to the other; others may have lymphoma misdiagnosed as IBD from the start. Periodic ultrasound is reasonable in long-term cases.
Is the special diet for life?
For most cats with diagnosed IBD or food-responsive enteropathy, yes. Reintroducing the prior diet usually triggers a relapse.
Are probiotics helpful?
Evidence is mixed but generally favorable for veterinary-specific products (FortiFlora, Proviable). Probiotics are adjunctive, not a substitute for a structured workup.